JP2024536126A5 - - Google Patents
Info
- Publication number
- JP2024536126A5 JP2024536126A5 JP2024519112A JP2024519112A JP2024536126A5 JP 2024536126 A5 JP2024536126 A5 JP 2024536126A5 JP 2024519112 A JP2024519112 A JP 2024519112A JP 2024519112 A JP2024519112 A JP 2024519112A JP 2024536126 A5 JP2024536126 A5 JP 2024536126A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- resmethirome
- item
- less
- items
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163248634P | 2021-09-27 | 2021-09-27 | |
| US63/248,634 | 2021-09-27 | ||
| PCT/US2022/044826 WO2023049491A1 (en) | 2021-09-27 | 2022-09-27 | Resmetirom for reducing liver volume |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536126A JP2024536126A (ja) | 2024-10-04 |
| JP2024536126A5 true JP2024536126A5 (https=) | 2025-10-08 |
Family
ID=83900064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519112A Pending JP2024536126A (ja) | 2021-09-27 | 2022-09-27 | 肝体積を減少させるためのレスメチロム |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20240408102A1 (https=) |
| EP (2) | EP4408428A1 (https=) |
| JP (1) | JP2024536126A (https=) |
| KR (1) | KR20240073926A (https=) |
| CN (1) | CN118251221A (https=) |
| AR (1) | AR127165A1 (https=) |
| AU (1) | AU2022348966A1 (https=) |
| CA (1) | CA3233319A1 (https=) |
| CL (1) | CL2024000886A1 (https=) |
| IL (1) | IL311670A (https=) |
| MX (1) | MX2024003967A (https=) |
| TW (1) | TW202337470A (https=) |
| WO (1) | WO2023049491A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121443313A (zh) * | 2023-06-08 | 2026-01-30 | 成都微芯药业有限公司 | PPAR全激动剂联合THR-β激动剂在抗代谢相关疾病中的用途 |
| WO2024263714A1 (en) * | 2023-06-22 | 2024-12-26 | Madrigal Pharmaceuticals, Inc. | BIOMARKERS FOR TREATING LIVER DISORDERS WITH THR-β AGONISTS AND RELATED USES |
| KR20260000642A (ko) * | 2024-06-25 | 2026-01-05 | 연세대학교 산학협력단 | Usp10 억제제를 유효성분으로 포함하는, 간섬유증 또는 간섬유증 관련 질환의 예방 또는 치료용 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR092872A1 (es) | 2012-09-17 | 2015-05-06 | Madrigal Pharmaceuticals Inc | Metodo para sintetizar analogos de la hormona tiroidea y polimorfos de los mismos |
| CA3111025C (en) * | 2018-09-06 | 2023-10-31 | Galmed Research And Development Ltd | Combination therapy for the treatment of liver disease |
-
2022
- 2022-09-27 CN CN202280075697.1A patent/CN118251221A/zh active Pending
- 2022-09-27 TW TW111136510A patent/TW202337470A/zh unknown
- 2022-09-27 JP JP2024519112A patent/JP2024536126A/ja active Pending
- 2022-09-27 US US18/695,572 patent/US20240408102A1/en active Pending
- 2022-09-27 EP EP22793025.2A patent/EP4408428A1/en not_active Withdrawn
- 2022-09-27 EP EP24212126.7A patent/EP4578499A3/en active Pending
- 2022-09-27 AR ARP220102600A patent/AR127165A1/es unknown
- 2022-09-27 AU AU2022348966A patent/AU2022348966A1/en active Pending
- 2022-09-27 KR KR1020247013928A patent/KR20240073926A/ko active Pending
- 2022-09-27 IL IL311670A patent/IL311670A/en unknown
- 2022-09-27 WO PCT/US2022/044826 patent/WO2023049491A1/en not_active Ceased
- 2022-09-27 CA CA3233319A patent/CA3233319A1/en active Pending
- 2022-09-27 MX MX2024003967A patent/MX2024003967A/es unknown
-
2024
- 2024-03-26 CL CL2024000886A patent/CL2024000886A1/es unknown
-
2025
- 2025-11-12 US US19/386,839 patent/US20260069598A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024536126A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| JP2024133474A5 (https=) | ||
| JP2023002544A5 (https=) | ||
| CA2867343C (en) | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | |
| JP2022191257A5 (https=) | ||
| Iqbal et al. | Ketamine for depression clinical issues | |
| JP2018521964A5 (https=) | ||
| JP2013533858A5 (https=) | ||
| JP2019530713A5 (https=) | ||
| IL314873A (en) | Compositions and methods for treating disorders ameliorated by muscarnic receptor activation | |
| JP2024528127A5 (https=) | ||
| JP2020504129A (ja) | 非アルコール性脂肪性肝炎（ｎａｓｈ）および肝線維症のための併用療法 | |
| JP2022554276A5 (https=) | ||
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2021534160A5 (https=) | ||
| JP2023553253A5 (https=) | ||
| JP2004525143A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| Pistono et al. | What’s new about oral treatments in Multiple Sclerosis? Immunogenetics still under question | |
| JP2023508250A5 (https=) | ||
| JP2024543345A5 (https=) | ||
| JP2017508737A5 (https=) | ||
| JP2019507785A5 (https=) | ||
| JP2022058873A5 (https=) |